Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, O.
Right arrow Articles by Nau, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, O.
Right arrow Articles by Nau, R.
Neurology 1999;53:1584
© 1999 American Academy of Neurology


Brief Communications

Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations

O. Schneider, MD, U. Michel, PhD, G. Zysk, MD, O. Dubuis, MD and R. Nau, MD

From the Department of Neurology (Drs. Schneider, Michel, and Nau), University of Göttingen, Germany; and the Departments of Medical Microbiology, University of Düsseldorf (Dr. Zysk), Germany, and University of Bern (Dr. Dubuis), Switzerland.

Address correspondence and reprint requests to Dr. Roland Nau, Department of Neurology, University Hospital, Robert-Koch-Straße 40, D-37075 Göttingen, Germany.

Lipoteichoic and teichoic acids are components of the cell wall of Streptococcus pneumoniae. A recently developed enzyme immunoassay was used in patients with pneumococcal meningitis to investigate lipoteichoic and teichoic acid concentrations in CSF at the first lumbar puncture in relation to the clinical outcome determined by the Glasgow Outcome Scale. Lipoteichoic and teichoic acid concentrations in CSF were significantly associated with neurologic sequelae and mortality in S. pneumoniae meningitis.

Key words: Lipoteichoic acid—Teichoic acid—Streptococcus pneumoniae—Meningitis—CSF.




This article has been cited by other articles:


Home page
Therapeutic Advances in Neurological DisordersHome page
O. Hoffman and J. R. Weber
Review: Pathophysiology and treatment of bacterial meningitis
Therapeutic Advances in Neurological Disorders, November 1, 2009; 2(6): 401 - 412.
[Abstract] [PDF]


Home page
J. Immunol.Home page
R. Bucki, F. J. Byfield, A. Kulakowska, M. E. McCormick, W. Drozdowski, Z. Namiot, T. Hartung, and P. A. Janmey
Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components
J. Immunol., October 1, 2008; 181(7): 4936 - 4944.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
O. Hoffmann, C. Mahrhofer, N. Rueter, D. Freyer, B. Bert, H. Fink, and J. R. Weber
Pneumococcal Cell Wall-Induced Meningitis Impairs Adult Hippocampal Neurogenesis
Infect. Immun., September 1, 2007; 75(9): 4289 - 4297.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Grandgirard, C. Schurch, P. Cottagnoud, and S. L. Leib
Prevention of Brain Injury by the Nonbacteriolytic Antibiotic Daptomycin in Experimental Pneumococcal Meningitis
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2173 - 2178.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Hoffmann, J. S. Braun, D. Becker, A. Halle, D. Freyer, E. Dagand, S. Lehnardt, and J. R. Weber
TLR2 Mediates Neuroinflammation and Neuronal Damage
J. Immunol., May 15, 2007; 178(10): 6476 - 6481.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Draing, M. Pfitzenmaier, S. Zummo, G. Mancuso, A. Geyer, T. Hartung, and S. von Aulock
Comparison of Lipoteichoic Acid from Different Serotypes of Streptococcus pneumoniae
J. Biol. Chem., November 10, 2006; 281(45): 33849 - 33859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. L. Hasty, S. Meron-Sudai, K. H. Cox, T. Nagorna, E. Ruiz-Bustos, E. Losi, H. S. Courtney, E. A. Mahrous, R. Lee, and I. Ofek
Monocyte and Macrophage Activation by Lipoteichoic Acid Is Independent of Alanine and Is Potentiated by Hemoglobin
J. Immunol., May 1, 2006; 176(9): 5567 - 5576.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. T. Brandt, J. D. Lundgren, S. P. Lund, N. Frimodt-Moller, T. Christensen, T. Benfield, F. Espersen, D. M. Hougaard, and C. Ostergaard
Attenuation of the Bacterial Load in Blood by Pretreatment with Granulocyte-Colony-Stimulating Factor Protects Rats from Fatal Outcome and Brain Damage during Streptococcus pneumoniae Meningitis
Infect. Immun., August 1, 2004; 72(8): 4647 - 4653.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Angstwurm, U.-K. Hanisch, T. Gassemi, M. B. Bille, M. Prinz, U. Dirnagl, H. Kettenmann, and J. R. Weber
Tyrosine Kinase Inhibition Reduces Inflammation in the Acute Stage of Experimental Pneumococcal Meningitis
Infect. Immun., June 1, 2004; 72(6): 3294 - 3298.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Lotz, E. Aga, I. Wilde, G. van Zandbergen, T. Hartung, W. Solbach, and T. Laskay
Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2
J. Leukoc. Biol., March 1, 2004; 75(3): 467 - 477.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. van der Flier, S. P. M. Geelen, J. L. L. Kimpen, I. M. Hoepelman, and E. I. Tuomanen
Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome?
Clin. Microbiol. Rev., July 1, 2003; 16(3): 415 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. W. J. Schroder, S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U. B. Gobel, J. R. Weber, and R. R. Schumann
Lipoteichoic Acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved
J. Biol. Chem., April 25, 2003; 278(18): 15587 - 15594.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Gerber, K. Pohl, V. Sander, S. Bunkowski, and R. Nau
Rifampin Followed by Ceftriaxone for Experimental Meningitis Decreases Lipoteichoic Acid Concentrations in Cerebrospinal Fluid and Reduces Neuronal Damage in Comparison to Ceftriaxone Alone
Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1313 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. Nau and H. Eiffert
Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis
Clin. Microbiol. Rev., January 1, 2002; 15(1): 95 - 110.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
A. P. Bhavsar, X. Zhao, and E. D. Brown
Development and Characterization of a Xylose-Dependent System for Expression of Cloned Genes in Bacillus subtilis: Conditional Complementation of a Teichoic Acid Mutant
Appl. Envir. Microbiol., January 1, 2001; 67(1): 403 - 410.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
M. P. Kozar, M. T. Krahmer, A. Fox, and B. M. Gray
Failure To Detect Muramic Acid in Normal Rat Tissues but Detection in Cerebrospinal Fluids from Patients with Pneumococcal Meningitis
Infect. Immun., August 1, 2000; 68(8): 4688 - 4698.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.